| Bioactivity | Topoisomerase I inhibitor 10 (compound 13) is a leishmanial topoisomerase IB inhibitor. Topoisomerase I inhibitor 10 has antileishmanial activity against L. donovani promastigotes, with the IC50 of 27.91 μM[1]. |
| Target | 27.91 μM |
| Name | Topoisomerase I inhibitor 10 |
| Formula | C35H35Br2FN2O10 |
| Molar Mass | 822.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kour P, et al. Design, synthesis, and biological evaluation of 3,3'-diindolylmethane N-linked glycoconjugate as a leishmanial topoisomerase IB inhibitor with reduced cytotoxicity. RSC Med Chem. 2023;14(10):2100-2114. Published 2023 Aug 30. |
Topoisomerase I inhibitor 10
CAS: F: C35H35Br2FN2O10 W: 822.47
Topoisomerase I inhibitor 10 (compound 13) is a leishmanial topoisomerase IB inhibitor. Topoisomerase I inhibitor 10 has
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.